This $171,135 Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports the development of Dr. Resmi Charalel's capacity to discover practical solutions for improving equitable access to treatment for patients with small hepatocellular carcinoma (HCC). The key objectives of this 5-year project include: 1) Identifying barriers and facilitators to timely treatment of small HCC through qualitative research; 2) Iteratively developing a multi-level intervention to address patient, provider, and system-level factors contributing to care delivery inequities; and 3) Conducting a pilot feasibility and acceptability study of the multi-level intervention at a tertiary care center and community hospital. This foundational work will enable Dr. Charalel to pursue a future randomized controlled trial to assess the efficacy of the novel intervention in improving timely treatment access and reducing disparities in small HCC care delivery.
Generated 3/25/25, 3:14 AM